Pramod Gautam

Pramod Gautam

Auto-generated profile, based on publicly available information

Pramod Gautam

Genome Sequencing Laboratory, Institute of Liver and Biliary Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Travel Medicine and Infectious Disease
Verified
Journal Article
Open access
RGRahul Garg
Rahul Garg
PGPramod Gautam
Pramod Gautam
VSVarun Suroliya
Varun Suroliya
RAReshu Agarwal
Reshu Agarwal
ABArjun Bhugra
Arjun Bhugra
EGEkta Gupta
Ekta Gupta

27 April 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
PGPramod Gautam
Pramod Gautam
DPDiptanu Paul
Diptanu Paul
VSVarun Suroliya
Varun Suroliya
RGRahul Garg
Rahul Garg
RAReshu Agarwal
Reshu Agarwal
EGEkta Gupta
Ekta Gupta
Genome surveillance of the Delhi data provides a more detailed picture of diverse circulating lineages. The added value that the current study provides by clinical details of the patients is of importance.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
PGPramod Gautam
Pramod Gautam
DPDiptanu Paul
Diptanu Paul
VSVarun Suroliya
Varun Suroliya
RGRahul Garg
Rahul Garg
RAReshu Agarwal
Reshu Agarwal
EGEkta Gupta
Ekta Gupta
Background: Since its advent, the pandemic has caused havoc in multiple waves due partly to amplified transmissibility and immune escape to vaccines. Delhi also witnessed brutal multiple peaks causing exponential rise in cases. Here we had retrospectively investigated clade variation, emergence of new lineages and varied clinical characteristics during those three peaks in order to understand the trajectory of the ongoing pandemic. Methods: In this study a total of 1,23,378 samples were collected for a time span of fourteen months (1st June 2020, to 3rd August, 2021) encompassing three different peaks in Delhi. A subset of 747 samples was processed for sequencing. Complete clinical and demographic details of all the enrolled cases were also collected. Findings: We detected 26 lineages across three peaks non-uniformly from 612 quality passed samples. The first peak was driven by diverse early variants, while the second one by B.1.36 and B.1.617.2, unlike third peak caused entirely by B.1.617.2. A total of 18316 mutations with median of 34 were reported. Majority of mutations were present in less than 1% of samples. Differences in clinical characteristics across three peaks was also reported. Interpretation: In order to be ahead of the frequently changing course of the ongoing pandemic, it is of utmost importance that novel lineages to be tracked continuously. Prioritized sequencing of sudden local outburst and community hotspots must be done in order to swiftly detect a novel mutation/lineage of potential clinical importance. Funding Information: WGS laboratory at our institute is funded by the Government of NCT, Delhi. Declaration of Interests: The authors declare no conflict of interest. Ethics Approval Statement: The present study was approved by Institutional Ethics Committee (IEC) at Institute of Liver and Biliary Sciences, New Delhi (Ethical no. IEC/2020/77/MA07). In this study de-identified and anonymised archived samples were subjected to whole genome sequencing. No personal details except clinically relevant information (age, sex, symptoms and outcome) were used for the purpose of the study. Hence individual consent form was waived off by the IEC.